IceCure Medical Ltd. Ordinary Shares
Follow $ICCM
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ICCM by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ICCM moving today?
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ICCM overview
Related filings and maps
Congress activity in ICCM
Congress disclosures unavailable.
ICCM contract awards, year to date.
Public federal awards linked to this ticker.
ICCM lobbying filings, year to date.
Registered lobbying filings matched to IceCure Medical Ltd. Ordinary Shares.